Future directions in regional treatment strategies for melanoma and sarcoma

G. M. Beasley, M. I. Ross, Douglas Tyler

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hyperthermic isolated limb perfusion (HILP) with melphalan and more recently isolated limb infusion (ILI) with melphalan +/- dactinomycin are common treatment modalities for both in-transit melanoma of the extremity and advanced extremity sarcoma. In order to further optimize treatment, future research should focus on selection of appropriate patients, verification of a technique that produces consistent results while maintaining acceptable toxicity, and development of novel strategies and agents. Development of these novel agents and strategies has potential to not only improve the efficacy of regional chemotherapy but may also help guide future strategies for systemic treatment.

Original languageEnglish (US)
Pages (from-to)301-309
Number of pages9
JournalInternational Journal of Hyperthermia
Volume24
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Sarcoma
Melanoma
Extremities
Melphalan
Dactinomycin
Therapeutics
Patient Selection
Perfusion
Drug Therapy
Direction compound

Keywords

  • Melanoma
  • Regional chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Radiological and Ultrasound Technology

Cite this

Future directions in regional treatment strategies for melanoma and sarcoma. / Beasley, G. M.; Ross, M. I.; Tyler, Douglas.

In: International Journal of Hyperthermia, Vol. 24, No. 3, 05.2008, p. 301-309.

Research output: Contribution to journalArticle

@article{a26262f89b5544918c3b72e63806e5f6,
title = "Future directions in regional treatment strategies for melanoma and sarcoma",
abstract = "Hyperthermic isolated limb perfusion (HILP) with melphalan and more recently isolated limb infusion (ILI) with melphalan +/- dactinomycin are common treatment modalities for both in-transit melanoma of the extremity and advanced extremity sarcoma. In order to further optimize treatment, future research should focus on selection of appropriate patients, verification of a technique that produces consistent results while maintaining acceptable toxicity, and development of novel strategies and agents. Development of these novel agents and strategies has potential to not only improve the efficacy of regional chemotherapy but may also help guide future strategies for systemic treatment.",
keywords = "Melanoma, Regional chemotherapy",
author = "Beasley, {G. M.} and Ross, {M. I.} and Douglas Tyler",
year = "2008",
month = "5",
doi = "10.1080/02656730701827573",
language = "English (US)",
volume = "24",
pages = "301--309",
journal = "International Journal of Hyperthermia",
issn = "0265-6736",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Future directions in regional treatment strategies for melanoma and sarcoma

AU - Beasley, G. M.

AU - Ross, M. I.

AU - Tyler, Douglas

PY - 2008/5

Y1 - 2008/5

N2 - Hyperthermic isolated limb perfusion (HILP) with melphalan and more recently isolated limb infusion (ILI) with melphalan +/- dactinomycin are common treatment modalities for both in-transit melanoma of the extremity and advanced extremity sarcoma. In order to further optimize treatment, future research should focus on selection of appropriate patients, verification of a technique that produces consistent results while maintaining acceptable toxicity, and development of novel strategies and agents. Development of these novel agents and strategies has potential to not only improve the efficacy of regional chemotherapy but may also help guide future strategies for systemic treatment.

AB - Hyperthermic isolated limb perfusion (HILP) with melphalan and more recently isolated limb infusion (ILI) with melphalan +/- dactinomycin are common treatment modalities for both in-transit melanoma of the extremity and advanced extremity sarcoma. In order to further optimize treatment, future research should focus on selection of appropriate patients, verification of a technique that produces consistent results while maintaining acceptable toxicity, and development of novel strategies and agents. Development of these novel agents and strategies has potential to not only improve the efficacy of regional chemotherapy but may also help guide future strategies for systemic treatment.

KW - Melanoma

KW - Regional chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=42049105856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049105856&partnerID=8YFLogxK

U2 - 10.1080/02656730701827573

DO - 10.1080/02656730701827573

M3 - Article

VL - 24

SP - 301

EP - 309

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

IS - 3

ER -